Fox Run Management’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,780
Closed -$91.6K 1218
2025
Q1
$91.6K Buy
+13,780
New +$91.6K 0.01% 862